ES2527210T3 - Células etiquetadas para su uso como un control interno funcional en ensayos de detección de células raras - Google Patents

Células etiquetadas para su uso como un control interno funcional en ensayos de detección de células raras Download PDF

Info

Publication number
ES2527210T3
ES2527210T3 ES10179790.0T ES10179790T ES2527210T3 ES 2527210 T3 ES2527210 T3 ES 2527210T3 ES 10179790 T ES10179790 T ES 10179790T ES 2527210 T3 ES2527210 T3 ES 2527210T3
Authority
ES
Spain
Prior art keywords
internal control
cell detection
detection assays
cells labeled
rare cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES10179790.0T
Other languages
English (en)
Inventor
Leon W. M. M. Terstappen
Galla Chandra Rao
Herman Rutner
Paul A. Liberti
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Diagnostics LLC
Original Assignee
Janssen Diagnostics LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Diagnostics LLC filed Critical Janssen Diagnostics LLC
Application granted granted Critical
Publication of ES2527210T3 publication Critical patent/ES2527210T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B03—SEPARATION OF SOLID MATERIALS USING LIQUIDS OR USING PNEUMATIC TABLES OR JIGS; MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C—MAGNETIC OR ELECTROSTATIC SEPARATION OF SOLID MATERIALS FROM SOLID MATERIALS OR FLUIDS; SEPARATION BY HIGH-VOLTAGE ELECTRIC FIELDS
    • B03C1/00—Magnetic separation
    • B03C1/005—Pretreatment specially adapted for magnetic separation
    • B03C1/01—Pretreatment specially adapted for magnetic separation by addition of magnetic adjuvants
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y25/00—Nanomagnetism, e.g. magnetoimpedance, anisotropic magnetoresistance, giant magnetoresistance or tunneling magnetoresistance
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
    • G01N15/10—Investigating individual particles
    • G01N15/14—Optical investigation techniques, e.g. flow cytometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • H—ELECTRICITY
    • H01—ELECTRIC ELEMENTS
    • H01F—MAGNETS; INDUCTANCES; TRANSFORMERS; SELECTION OF MATERIALS FOR THEIR MAGNETIC PROPERTIES
    • H01F1/00—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties
    • H01F1/0036—Magnets or magnetic bodies characterised by the magnetic materials therefor; Selection of materials for their magnetic properties showing low dimensional magnetism, i.e. spin rearrangements due to a restriction of dimensions, e.g. showing giant magnetoresistivity
    • H01F1/0045—Zero dimensional, e.g. nanoparticles, soft nanoparticles for medical/biological use
    • H01F1/0054—Coated nanoparticles, e.g. nanoparticles coated with organic surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Nanotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Un método para detectar y enumerar células raras en una población de células mezcladas, siendo la presencia de dichas células raras en dicha población indicativa de la severidad de una enfermedad, que comprende: a) Preparar una muestra inmunomagnética en la que una muestra de sangre obtenida de un sujeto de prueba se mezcla con partículas magnéticas, dicha muestra comprende una población de células mezcladas que se cree que contiene dichas células raras y dichas partículas magnéticas se acoplan a un ligando que reacciona específicamente con un determinante de las células raras para la exclusión sustancial de otros componentes de la muestra. b) Poner en contacto dicha muestra inmunomagnética con, al menos, un reactivo que marca un determinante de las células raras; y c) analizar las células raras marcadas para determinar la presencia y el número de cualquiera de las células raras en la muestra inmunomagnética, el mayor número de células raras presentes en dicha muestra, la mayor severidad de la enfermedad, donde la célula de control tiene determinantes en común con las células raras y en la que la membrana de dicha célula de control se encuentra marcada de forma detectable y los componentes celulares y restos antigénicos de la célula de control han sido estabilizados durante un período de hasta seis meses mediante la exposición a un fijador, donde, opcionalmente, dicha célula rara es una célula cancerígena y dicha enfermedad es cáncer.

Description

imagen1
imagen2
imagen3
imagen4
imagen5
imagen6
imagen7
imagen8
imagen9
imagen10
imagen11
imagen12
imagen13
imagen14
imagen15
imagen16
imagen17
imagen18
imagen19
imagen20
imagen21

Claims (1)

  1. imagen1
ES10179790.0T 2001-03-07 2002-03-07 Células etiquetadas para su uso como un control interno funcional en ensayos de detección de células raras Expired - Lifetime ES2527210T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/801,471 US20010018192A1 (en) 1998-02-12 2001-03-07 Labeled cells for use as an internal functional control in rare cell detection assays
US801471 2001-03-08

Publications (1)

Publication Number Publication Date
ES2527210T3 true ES2527210T3 (es) 2015-01-21

Family

ID=25181182

Family Applications (2)

Application Number Title Priority Date Filing Date
ES10179790.0T Expired - Lifetime ES2527210T3 (es) 2001-03-07 2002-03-07 Células etiquetadas para su uso como un control interno funcional en ensayos de detección de células raras
ES02739098T Expired - Lifetime ES2357101T3 (es) 2001-03-07 2002-03-07 Celulas marcadas para su uso como control funcional interno en ensayos de detección de celulas raras.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES02739098T Expired - Lifetime ES2357101T3 (es) 2001-03-07 2002-03-07 Celulas marcadas para su uso como control funcional interno en ensayos de detección de celulas raras.

Country Status (11)

Country Link
US (1) US20010018192A1 (es)
EP (2) EP2280283B1 (es)
JP (1) JP2004534210A (es)
AT (1) ATE490466T1 (es)
AU (1) AU2002311773A1 (es)
DE (1) DE60238493D1 (es)
DK (1) DK2280283T3 (es)
ES (2) ES2527210T3 (es)
HK (1) HK1152378A1 (es)
PT (1) PT2280283E (es)
WO (1) WO2002077604A2 (es)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7282350B2 (en) 1998-02-12 2007-10-16 Immunivest Corporation Labeled cell sets for use as functional controls in rare cell detection assays
GB2361996B (en) * 1998-10-29 2004-05-12 Cell Works Inc Multiple marker characterization of single cells
US8980568B2 (en) 2001-10-11 2015-03-17 Aviva Biosciences Corporation Methods and compositions for detecting non-hematopoietic cells from a blood sample
US8986944B2 (en) 2001-10-11 2015-03-24 Aviva Biosciences Corporation Methods and compositions for separating rare cells from fluid samples
EP1481248A2 (en) * 2002-03-01 2004-12-01 Cardiff & Vale National Health service Trust Universitiy Hospital of Wales Methods for absolute cell counting
WO2004029221A2 (en) 2002-09-27 2004-04-08 The General Hospital Corporation Microfluidic device for cell separation and uses thereof
DK1816461T3 (da) 2002-10-16 2020-04-14 Streck Laboratories Inc Fremgangsmåde og indretning til indsamling og sikring af celler til brug for analyse
DE602004030220D1 (de) 2003-02-27 2011-01-05 Veridex Llc ZIRKULIERENDE TUMORZELLEN (CTC's): FRÜHE BEURTEILUNG VON TIME-TO-PROGRESSION, ÜBERLEBEN UND ANSPRECHEN AUF THERAPIE BEI PATIENTEN MIT METASTASIERTEM KREBS
WO2005028663A2 (en) * 2003-09-18 2005-03-31 Immunivest Corporation Operator independent programmable sample preparation and analysis system
JP2007506430A (ja) * 2003-09-23 2007-03-22 ユニヴァーシティー オブ ミズーリ 耐熱性酵素を使用するポリヌクレオチド合成方法
US20050181353A1 (en) * 2004-02-17 2005-08-18 Rao Galla C. Stabilization of cells and biological specimens for analysis
US20070196820A1 (en) 2005-04-05 2007-08-23 Ravi Kapur Devices and methods for enrichment and alteration of cells and other particles
US8921102B2 (en) 2005-07-29 2014-12-30 Gpb Scientific, Llc Devices and methods for enrichment and alteration of circulating tumor cells and other particles
US20070128668A1 (en) * 2005-12-01 2007-06-07 Larry Burg Quantitative use of tracer cells
US8337755B2 (en) 2006-03-13 2012-12-25 Veridex, Llc Operator independent programmable sample preparation and analysis system
CA2653745C (en) 2006-06-02 2013-11-19 Pfizer Products Inc. Circulating tumor cell assay
CA2657621A1 (en) 2006-07-14 2008-01-17 Aviva Biosciences Corporation Methods and compositions for detecting rare cells from a biological sample
US7828968B2 (en) 2007-08-30 2010-11-09 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
US8110101B2 (en) 2007-08-30 2012-02-07 Veridex, Llc Method and apparatus for imaging target components in a biological sample using permanent magnets
MX2010005811A (es) * 2007-11-27 2010-06-09 Veridex Llc Enumeracion automatica y caracterizacion de las celulas del melanoma circulantes en la sangre.
WO2010068812A1 (en) 2008-12-10 2010-06-17 Abqmr, Inc. Nuclear magnetic resonance apparatus, methods and associated technology
US11634747B2 (en) * 2009-01-21 2023-04-25 Streck Llc Preservation of fetal nucleic acids in maternal plasma
DK3290530T3 (da) 2009-02-18 2020-12-07 Streck Inc Konservering af cellefrie nukleinsyrer
WO2011057184A1 (en) * 2009-11-09 2011-05-12 Streck, Inc. Stabilization of rna in and extracting from intact cells within a blood sample
US9476812B2 (en) 2010-04-21 2016-10-25 Dna Electronics, Inc. Methods for isolating a target analyte from a heterogeneous sample
US8841104B2 (en) 2010-04-21 2014-09-23 Nanomr, Inc. Methods for isolating a target analyte from a heterogeneous sample
US9428547B2 (en) 2010-04-21 2016-08-30 Dna Electronics, Inc. Compositions for isolating a target analyte from a heterogeneous sample
US20110262989A1 (en) 2010-04-21 2011-10-27 Nanomr, Inc. Isolating a target analyte from a body fluid
JP6323978B2 (ja) 2010-12-24 2018-05-16 アークレイ株式会社 癌細胞の検出方法
WO2012151391A2 (en) 2011-05-04 2012-11-08 Streck, Inc. Inactivated virus compositions and methods of preparing such compositions
JP6133297B2 (ja) * 2011-09-06 2017-05-24 ベクトン・ディキンソン・アンド・カンパニーＢｅｃｔｏｎ， Ｄｉｃｋｉｎｓｏｎ Ａｎｄ Ｃｏｍｐａｎｙ 試料中の希少標的細胞のサイトメトリー検出のための方法及び組成物
US20150056649A1 (en) 2012-01-13 2015-02-26 Konica Minolta, Inc. Method for quantifying cell of interest in blood, and method for evaluating system for quantifying said cell
WO2014052875A1 (en) 2012-09-27 2014-04-03 Cynvenio Biosystems, Inc. Stimulus-sensitive microparticles and methods of use
WO2014074737A1 (en) * 2012-11-07 2014-05-15 Sandstone Diagnostics, Inc. Methods and devices for processing samples and counting cells
US9804069B2 (en) 2012-12-19 2017-10-31 Dnae Group Holdings Limited Methods for degrading nucleic acid
US9434940B2 (en) 2012-12-19 2016-09-06 Dna Electronics, Inc. Methods for universal target capture
US9551704B2 (en) 2012-12-19 2017-01-24 Dna Electronics, Inc. Target detection
US9599610B2 (en) 2012-12-19 2017-03-21 Dnae Group Holdings Limited Target capture system
US9995742B2 (en) 2012-12-19 2018-06-12 Dnae Group Holdings Limited Sample entry
US10000557B2 (en) 2012-12-19 2018-06-19 Dnae Group Holdings Limited Methods for raising antibodies
WO2014124179A1 (en) 2013-02-07 2014-08-14 Sandstone Diagnostics, Inc. Automated sample processing, fluid distribution, and sedimentation assay
US20150233932A1 (en) * 2013-02-19 2015-08-20 Ching-Ping Tseng Methods, Systems, and Compositions for Enrichment of Rare Cells
EP4136972A1 (en) 2013-07-24 2023-02-22 Streck, Inc. Compositions and methods for stabilizing circulating tumor cells
US20160178614A1 (en) * 2013-08-02 2016-06-23 Siemens Healthcare Diagnostics Inc. Cell-based control and method
JP6331524B2 (ja) * 2014-03-14 2018-05-30 日立化成株式会社 標準細胞液
CN104568923A (zh) * 2014-12-01 2015-04-29 浙江省肿瘤医院 电化学发光检测外周血循环肿瘤细胞抗原的方法及试剂盒
US11168351B2 (en) 2015-03-05 2021-11-09 Streck, Inc. Stabilization of nucleic acids in urine
JP6582486B2 (ja) * 2015-03-27 2019-10-02 コニカミノルタ株式会社 血液中の稀少細胞検出方法
US20170145475A1 (en) 2015-11-20 2017-05-25 Streck, Inc. Single spin process for blood plasma separation and plasma composition including preservative
US11506655B2 (en) 2016-07-29 2022-11-22 Streck, Inc. Suspension composition for hematology analysis control
JP6485576B2 (ja) * 2018-04-19 2019-03-20 日立化成株式会社 標準細胞液

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5188935A (en) * 1984-05-31 1993-02-23 Coulter Electronics, Inc. Reagent system and method for identification, enumeration and examination of classes and subclasses of blood leukocytes
US4795698A (en) * 1985-10-04 1989-01-03 Immunicon Corporation Magnetic-polymer particles
US5597531A (en) * 1985-10-04 1997-01-28 Immunivest Corporation Resuspendable coated magnetic particles and stable magnetic particle suspensions
US5187099A (en) * 1986-10-29 1993-02-16 Coulter Corporation Control slide for immunoassay kit using a low-temperature melting paraffin
JP2619911B2 (ja) 1988-04-08 1997-06-11 東亜医用電子株式会社 網状赤血球測定装置用標準血液
US5059518A (en) * 1988-10-20 1991-10-22 Coulter Corporation Stabilized lyophilized mammalian cells and method of making same
US5698271A (en) * 1989-08-22 1997-12-16 Immunivest Corporation Methods for the manufacture of magnetically responsive particles
US5610022A (en) * 1989-09-26 1997-03-11 City Of Hope Internal control for immunocytochemistry assay
IE76319B1 (en) 1990-07-23 1997-10-22 Becton Dickinson Co Preservation of cells as controls or standards in cellular analysis
US5478722A (en) * 1991-02-17 1995-12-26 The Curators Of The University Of Missouri Preserved cell preparations for flow cytometry and immunology
US5270208A (en) * 1991-05-09 1993-12-14 Streck Laboratories, Inc. White blood cell hematology control
ATE193603T1 (de) * 1992-02-24 2000-06-15 Coulter Corp Suspensionsmedien für hämatoligische zusammensetzungen und methode für ihren gebrauch
WO1993018397A1 (en) * 1992-03-02 1993-09-16 Streck Laboratories, Inc. Reference control for use with manual and flow cytometric reticulocyte counting devices
US5763204A (en) * 1992-09-14 1998-06-09 Coulter Corporation Preparation of preserved, non-infectious control cell for use in the identification of a disease through blood testing
US5342754A (en) * 1992-09-14 1994-08-30 Coulter Corporation Preserved, non-infectious control cell for use in the identification of a disease through blood testing
WO1994016314A1 (en) * 1993-01-08 1994-07-21 Coulter Corporation Method of using preserved control cells in the calibration of fluorescent and light scatter measurements
DE69428552T2 (de) * 1993-01-26 2002-04-11 Becton Dickinson And Co., Franklin Lakes Verfahren zum Nachweis von seltenen Ereignissen
US5629933A (en) * 1995-06-07 1997-05-13 International Business Machines Corporation Method and system for enhanced communication in a multisession packet based communication system
JP3875754B2 (ja) * 1995-11-17 2007-01-31 シスメックス株式会社 フローサイトメータ用標準液
US5985153A (en) * 1996-06-07 1999-11-16 Immunivest Corporation Magnetic separation apparatus and methods employing an internal magnetic capture gradient and an external transport force
US5968831A (en) * 1996-10-29 1999-10-19 Coulter International Corp. Cell control used to confirm enzymatic activity
US6753190B1 (en) * 1998-07-01 2004-06-22 Nitto Denko Corporation Immunologic test method and immunologic test kit
AU763162B2 (en) * 1999-04-13 2003-07-17 Wilex Ag Diagnostic and therapeutic use of antibodies against the urokinase receptor
GB0022017D0 (en) * 2000-09-08 2000-10-25 Univ Dundee Cell assays

Also Published As

Publication number Publication date
EP2280283B1 (en) 2014-10-15
DK2280283T3 (en) 2014-11-17
EP1429603B1 (en) 2010-12-01
WO2002077604A2 (en) 2002-10-03
EP1429603A4 (en) 2004-08-18
US20010018192A1 (en) 2001-08-30
PT2280283E (pt) 2015-02-03
AU2002311773A1 (en) 2002-10-08
EP2280283A1 (en) 2011-02-02
DE60238493D1 (de) 2011-01-13
JP2004534210A (ja) 2004-11-11
ES2357101T3 (es) 2011-04-18
WO2002077604A3 (en) 2004-04-01
HK1152378A1 (en) 2012-02-24
ATE490466T1 (de) 2010-12-15
EP1429603A2 (en) 2004-06-23

Similar Documents

Publication Publication Date Title
ES2527210T3 (es) Células etiquetadas para su uso como un control interno funcional en ensayos de detección de células raras
MXPA02005796A (es) Tira de prueba electroquimica para usarse en la determinacion de analitos.
ITTO20010411A0 (it) Metodo e dispositivo per l'esecuzione di test e saggi ad alta processivita' ed alto valore biologico su cellule e/o composti.
AU2002230650A1 (en) Method for diagnosing pathology in biological samples
DE69823014D1 (de) Biochemisches und immunochemisches testgerät
NO20032961D0 (no) Flytende brenselblandinger for elektrokjemiske brenselceller
MX2007012486A (es) Ensayos de investigacion sobre estilbazio.
DK1432786T3 (da) Hurtig detektion af replikerede celler
EP0880699A4 (en) DISPLACEMENT TEST ON A POROUS MEMBRANE
BRPI0002963B8 (pt) processo e dispositivo medidor eletroquímico para medir uma concentração de analito em uma amostra.
AU2001237981A1 (en) Immunochromatographic methods for detecting an analyte in a sample which employ semiconductor nanocrystals as detectable labels
DE60113619D1 (de) Wärmekontrollsystem für eine elektrochemische Zelle
DE60038403D1 (de) Abtastende Fluoreszenznachweisvorrichtung für Mehrfachproben.
AU2002360476A1 (en) Electro-chemical analysis device with integrated thermal sensor
PT1329724E (pt) Dispositivo e metodo de doeseamento de lipoproteina de alta densidade
WO2000062064A3 (en) Quality control for cytochemical assays
WO2004049909A3 (en) Device for sample collection and storage
AU2002364120A1 (en) Sensor for the use in testing biological chemical or environmental samples
DE69732034D1 (de) Assay-verfahren
WO2003093796A3 (en) Sample preparation method and device
ATE405837T1 (de) Festphase immunochromatographische testverfahren
AR022861A1 (es) Un dispositivo de analisis que incluye discos con almohadilla de inoculacion y metodos de uso
CA2407760A1 (en) Methods for diagnosis of low grade astrocytoma
AU2001277625A1 (en) Electrochemical strip test for small volumes
AU4429401A (en) Improved device for sample analysis by multiple capillary electrophoresis with solid/solid thermal control